HYPERTENSION IN CKD MARKET ANALYSIS

Market Challenges And Opportunities

Global Hypertension in CKD Market – Drivers

• Increasing collaboration for conducting research and development activities: Increasing collaboration for conducting research and development activities is expected to propel the growth of the global hypertension in CKD market over the forecast period. For instance, in March 2021, Fresenius Medical Care AG & Co. KGaA, a Germany-based global healthcare company, announced a three-way merger with InterWell Health, the leading physician organization driving innovation in the kidney care space in the U.S., and Cricket Health, a U.S. provider of value-based kidney care with a leading patient engagement and data platform, entered into a binding agreement to create an independent new company. The merger brings together Fresenius Health Partners’ expertise in kidney care value-based contracting and performance, InterWell Health’s clinical care models and strong network of 1,600 nephrologists, and Cricket Health’s tech-enabled care model that utilizes its proprietary informatics, StageSmart, and patient engagement platforms to create an innovative, stand-alone entity poised to transform kidney care.
• Increasing prevalence of chronic kidney diseases: Increasing prevalence of chronic kidney diseases is expected to increase the demand for new treatment options, thereby driving the global hypertension in CKD market growth. For instance, according to the Kidney International Supplements article ‘Epidemiology of chronic kidney disease: an update 2022 published in March 2022, Chronic kidney diseases affect around 10% of the general population worldwide, amounting to 800 Mn individuals globally. Chronic kidney disease is more prevalent in older individuals, women, racial minorities, and people experiencing diabetes mellitus and hypertension. Chronic kidney disease represents an especially large burden in low- and middle-income countries, which are least equipped to deal with its consequences. Chronic kidney disease has emerged as one of the leading causes of mortality worldwide.
• Global Hypertension in CKD Market : Drivers
• Increasing prevalence of chronic kidney diseases
• Emerging novel therapies and combination drugs
• Increasing funding and grants for research development

• Increasing government inititatives
• Technological Advancements
• Growing elderly population
• Increasing public awareness campaigns

• Lack of awareness about chronic kidney disease

Global Hypertension in CKD Market : Restraint

Lack of awareness about chronic kidney disease

• Lack of awareness about chronic kidney disease is the major factor that is expected to restrain growth of the global hypertension in CKD market over the forecast period. Despite the attempts made by governments in order to increase awareness among the population about chronic kidney disease (CKD) through different ways, such as the dissemination of clinical practice guidelines and recommendations for patients with CKD or its risk factors, community awareness on events such as World Kidney Day, and free screening for high-risk individuals such as the Kidney Early Evaluation Program (KEEP), it has been found that the awareness of CKD among the population remains unacceptably low. For instance, in December 2022, according to the study published in the BMC Public Health, for chronic kidney disease evaluation, it was reported that the people in Australia have a very poor understanding of chronic kidney disease (CKD), and only half of the participants knew about the availability of medications and also their role in slowing down the worsening of CKD.
• However, there are Public Awareness Campaigns organized from Health organizations and governments can launch campaigns to educate the public about the risks and symptoms of CKD.